BNTC: Benitec Biopharma Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
86 institutions reported holding $463.63M of Benitec Biopharma Inc. on Form 13F (88 the quarter before). 10 opened a new position and 10 sold out. Shares held by institutions: +7%.
| Largest holders | Shares | Value |
|---|---|---|
| MONTANOVA CAPITAL, LLC | 11,548,351 | $154.52M |
| Nantahala Capital Management, LLC | 2,976,742 | $39.83M |
| Jupiter Topco LLC | 2,478,547 | $33.11M |
| FRANKLIN RESOURCES INC | 2,412,888 | $32.28M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,120,672 | $28.37M |
| RA CAPITAL MANAGEMENT, L.P. | 1,850,000 | $24.75M |
| BlackRock, Inc. | 1,407,138 | $18.83M |
| Simplify Asset Management Inc. | 1,005,557 | $13.45M |
| VANGUARD CAPITAL MANAGEMENT LLC | 954,533 | $12.77M |
| INFINITUM ASSET MANAGEMENT, LLC | 923,006 | $12.35M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.